Decreased dopamine D2 receptor binding in essential blepharospasm

被引:23
|
作者
Horie, C. [1 ,2 ]
Suzuki, Y. [1 ,2 ]
Kiyosawa, M. [2 ]
Mochizuki, M. [2 ]
Wakakura, M. [3 ]
Oda, K. [1 ]
Ishiwata, K. [1 ]
Ishii, K. [1 ]
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan
[3] Inouye Eye Hosp, Tokyo, Japan
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 01期
关键词
dopamine D-2 receptor; essential blepharospasm; positron emission tomography; C-11]raclopride; DOPA-RESPONSIVE DYSTONIA; POSITRON-EMISSION-TOMOGRAPHY; BASAL GANGLIA; C-11; RACLOPRIDE; FOCAL DYSTONIA; D2; RECEPTORS; INHIBITION; PET; MUTATION; CARRIERS;
D O I
10.1111/j.1600-0404.2008.01053.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to investigate whether dopamine D-2 receptor binding was altered in the striatum of essential blepharospasm patients. Striatal dopamine D-2 receptor binding was measured with positron emission tomography and [C-11]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls. The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group. This study indicates decreased dopamine D-2 receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D-2 receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [1] Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain
    Karlsson, Henry K.
    Tuominen, Lauri
    Tuulari, Jetro J.
    Hirvonen, Jussi
    Parkkola, Riitta
    Helin, Semi
    Salminen, Paulina
    Nuutila, Pirjo
    Nummenmaa, Lauri
    JOURNAL OF NEUROSCIENCE, 2015, 35 (09): : 3959 - 3965
  • [2] Effect of Dopamine D2 Receptor Antagonists on [18F]-FEOBV Binding
    Schildt, Anna
    de Vries, Erik F. J.
    Willemsen, Antoon T. M.
    Giacobbo, Bruno Lima
    Moraga-Amaro, Rodrigo
    Sijbesma, Jurgen W. A.
    van Waarde, Aren
    Sossi, Vesna
    Dierckx, Rudi A. J. O.
    Doorduin, Janine
    MOLECULAR PHARMACEUTICS, 2020, 17 (03) : 865 - 872
  • [3] Transient equilibrium determination of dopamine D2/D3 receptor densities and affinities in brain
    Phan, Jenny-Ann
    Wong, Dean F.
    Chang, Natalie H. S.
    Kumakura, Yoshitaka
    Bauer, William R.
    Gjedde, Albert
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2
  • [4] Extrastriatal Dopamine D2 Receptor Binding in Huntington's Disease
    Esmaeilzadeh, Mouna
    Farde, Lars
    Karlsson, Per
    Varrone, Andrea
    Halldin, Christer
    Waters, Susanna
    Tedroff, Joakim
    HUMAN BRAIN MAPPING, 2011, 32 (10) : 1626 - 1636
  • [5] Decreased Striatal Dopamine Receptor Binding in Primary Focal Dystonia: A D2 or D3 Defect?
    Karimi, Morvarid
    Moerlein, Stephen M.
    Videen, Tom O.
    Luedtke, Robert R.
    Taylor, Michelle
    Mach, Robert H.
    Perlmutter, Joel S.
    MOVEMENT DISORDERS, 2011, 26 (01) : 100 - 106
  • [6] Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum
    Prasad, Kavya
    de Vries, Erik F. J.
    Sijbesma, Jurgen W. A.
    Garcia-Varela, Lara
    Vazquez-Matias, Daniel A.
    Moraga-Amaro, Rodrigo
    Willemsen, Antoon T. M.
    Dierckx, Rudi A. J. O.
    van Waarde, Aren
    MOLECULAR PHARMACEUTICS, 2022, 19 (08) : 2992 - 3001
  • [7] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Berry, Anne S.
    Shah, Vyoma D.
    Furman, Daniella J.
    White, Robert L., III
    Baker, Suzanne L.
    O'Neil, James P.
    Janabi, Mustafa
    D'Esposito, Mark
    Jagust, William J.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (06) : 1201 - 1211
  • [8] Altered dopamine D2 receptor binding in atypical facial pain
    Hagelberg, N
    Forssell, H
    Aalto, S
    Rinne, JO
    Scheinin, H
    Taiminen, T
    Någren, K
    Eskola, O
    Jääskeläinen, SK
    PAIN, 2003, 106 (1-2) : 43 - 48
  • [9] Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy
    Landvogt, Christian
    Buchholz, Hans-Georg
    Bernedo, Viviane
    Schreckenberger, Mathias
    Werhahn, Konrad J.
    EPILEPSIA, 2010, 51 (09) : 1699 - 1706
  • [10] μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
    Hagelberg, N
    Kajander, JK
    Någren, K
    Hinkka, S
    Hietala, J
    Scheinin, H
    SYNAPSE, 2002, 45 (01) : 25 - 30